BioSpace News Archive

Deals

J&J to Purchase Antibody-Drug Conjugate Company Ambrx for $2 Billion

The pharmaceutical giant will pay $28 a share to acquire Ambrx’s pipeline of ADCs, particularly its lead candidate for prostate cancer.

January 8, 2024
·
2 min read
·
Connor Lynch
JPM2024: On the Ground in San Francisco

BioSpace continues to bring you the latest news and industry developments from the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. Stay tuned!

January 8, 2024
·
22 min read
·
BioSpace Editorial Staff
Policy

Companies Bend Patent System to Head Off Competition Long-Term: Analysis

Brand pharmas not only leverage ancillary patents but sometimes hide or misrepresent information to the U.S. patent office in order to extend market exclusivity and high prices.

January 8, 2024
·
5 min read
·
Sunitha Chari
Business

Novartis’s Dealmaking Spree Continues with Calypso Buyout, Shanghai Argo RNAi Collab

A day after inking an AI deal with Alphabet’s Isomorphic Labs, Novartis is back at it, acquiring Calypso Biotech and tying up with Shanghai Argo in two RNA-i-focused pacts.

January 8, 2024
·
2 min read
·
Tristan Manalac
Policy

Biopharma Policy in the Spotlight at JPM as Sector Gears Up for Volatile 2024

The Inflation Reduction Act, “march-in rights” to take back patents and M&A were among the issues discussed at a Sunday panel in San Francisco ahead of Monday’s start of the J.P. Morgan conference.

January 8, 2024
·
4 min read
·
Greg Slabodkin
Policy

Listen: JPM2024 Day 1 Highlights

The BioSpace team is recording from San Francisco as they bring you the the latest highlights from JPM2024.

January 8, 2024
·
1 min read
Policy

Two Patient Deaths Force Vertex to Pause Diabetes Trial

The patient deaths were deemed unrelated to Vertex’s investigational islet cell therapy, but the study will be halted while regulatory authorities and an independent data monitoring committee review the findings.

January 8, 2024
·
2 min read
·
Tristan Manalac
Business

Lilly, Novartis Sign AI Partnership with Alphabet’s Isomorphic

The multimillion-dollar collaboration will develop small molecule drugs against undisclosed targets.

January 8, 2024
·
2 min read
·
Tristan Manalac
Deals

Merck to Buy Cancer Immunotherapy Biotech Harpoon for $680 Million

Harpoon has several antibodies in its pipeline that are engineered to redirect a patient’s T cells to recognize and kill cancer cells.

January 8, 2024
·
1 min read
·
David Adam
Deals

Metagenomi, ArriVent Launch Bid for Nasdaq

The IPO window is starting to crack open this year, with Metagenomi and ArriVent making their offerings ahead of the J.P. Morgan Healthcare Conference.

January 8, 2024
·
2 min read
·
Tristan Manalac